Roka Bioscience (ROKA) Reports Q2 Loss of $0.43

August 5, 2016 8:10 AM EDT
Get Alerts ROKA Hot Sheet
Trade ROKA Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Roka Bioscience (NASDAQ: ROKA) reported Q2 EPS of ($0.43), versus ($0.54) reported last year. Revenue for the quarter came in at $1.82 million, versus $1.47 million reported last year.

For earnings history and earnings-related data on Roka Bioscience (ROKA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment